Description

Imatib Tablet is an oral targeted antineoplastic (anti-cancer) medication manufactured by Cipla Ltd. While it is widely commercialised in 100 mg and 400 mg strengths, if a patient requires a total daily intake of 500 mg, their oncologist will usually fulfill this dose by combining a standard 400 mg tablet and a 100 mg tablet taken together